Factors affecting the accuracy of anti-BRAF V600E immunohistochemistry results in ameloblastomas.
Julia Yu Fong ChangPei Hsuan LuChih-Huang TsengYi-Ping WangJang-Jaer LeeChun-Pin ChiangPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2023)
The BRAF V600E-specific antibody immunohistochemistry is suitable for routine detection of BRAF V600E mutation in ameloblastomas. The all or none expression pattern suggests the BRAF V600E mutation may be an early event in the pathogenesis of ameloblastoma.